Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1995 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 8,830,920 |
| Marketable Securities | 4,083,240 |
| Receivables | 5,250,840 |
| Inventories | 6,179,880 |
| Other current assets | 1,983,240 |
| TOTAL | $26,328,120 |
| Non-Current Assets | |
| PPE Net | 12,990,600 |
| Investments And Advances | 2,852,640 |
| Other Non-Current Assets | 574,560 |
| TOTAL | $16,417,800 |
| Total Assets | $42,745,920 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 11,896,080 |
| TOTAL | $11,896,080 |
| Non-Current Liabilities | |
| Long Term Debt | 4,694,760 |
| Other Non-Current Liabilities | 3,753,960 |
| TOTAL | $9,408,000 |
| Total Liabilities | $21,304,080 |
| Shareholders' Equity | |
| Common Shares | 1,178,520 |
| Other shareholders' equity | 20,318,320 |
| TOTAL | $21,441,840 |
| Total Liabilities And Equity | $42,745,920 |